EpiWatch is an epilepsy research study that monitors seizure symptoms with Apple Watch to improve seizure detection, improve medication adherence and enhance quality of life for those who suffer from seizures.
Johns Hopkins researchers today introduced EpiWatch, designed to use Apple Watch to collect patient data through the open source ResearchKit framework designed by Apple. The app, which runs on Apple Watch and iPhone, collects data from patients with epilepsy before, during and after their seizures.
Over 2.5 million people are living with epilepsy in the United States. The data gathered by the app, including physiological changes, altered responsiveness and other characteristics of recurrent seizures, will be used by researchers to better understand epilepsy and to develop new methods for monitoring and managing the disease and the role of technology.
"Physicians often ask patients to record their seizures. But that
A proposed Canadian project called Prevention of Ongoing Comorbidities through Early Intervention in Youth Living with Epilepsy (POPEYE), is conducting a survey to collect preliminary data. This anonymous survey is about opinions related to genetic testing for neurodevelopmental disorders in children with Epilepsy. Click here to take the survey.
If you have the opportunity through your workplace to donate to a charity through United Way's Corporate Campaign this year, and would like your donation to support Epilepsy Durham Region, please indicate 'Other' on your donation form, and include Epilepsy Durham Region's charitable registration number.
Epilepsy Durham Region | Charitable Registration Number: 89670-5399-RR0001
Epilepsy Durham Region is proud to announce that we will be hosting Everything Epilepsy • A Parent's Forum on Saturday, October 24th, 2015 from 10:00 a.m. to 3:00. p.m. This is a day for parents and caregivers of people living with Epilepsy to learn, have questions answered, and meet other families who are also touched by Epilepsy.
DR. DARYOUSH GHARGHI | MD, MSc, FRCPC |
Adult Neurologist, Epileptologist & Clinical Neurophysiologist
Epilepsy 101 | Medications and Treatments | Psychosocial Impacts
Dr. Daryoush Gharghi completed his MD in Iran in 1998. He then completed his MSc in Neurological Sciences at McGill University in 2005 followed by a residency in Adult Neurology at the University of Toronto from 2007-2012. Dr. Gharghi also has a fellowship in Epilepsy and Clinical Neurophysiology
U.S. pharmaceutical company sues Canadian Government Review Board regarding medication pricing which may directly impact the cost of all medications in Canada. To learn more about this story, please visit the following links: